LENZ Expands Eye Drug Reach
LENZ Therapeutics announces an exclusive licensing and commercialization agreement with Arrotex Pharmaceuticals for its eye drop therapy in Australia and New Zealand
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.